ArticleOrphanet journal of rare diseases2013

Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries.

Thomas Morel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.